Size-exclusion chromatography, or SEC, is often used to estimate high-molecular-weight species, monomer, and fragments in protein and peptide-related materials. Its separation principle is simple: larger species are excluded from more of the column's pores and generally elute earlier, while smaller species explore more pore volume and elute later.
The output is not a direct count of molecular weight. It is a method-dependent profile of hydrodynamic behavior under the chosen solution and column conditions.
Apparent size is shaped by conformation
Two molecules with the same molecular weight can have different hydrodynamic volumes if one is compact and the other extended. A nonglobular monomer can elute where a globular molecular-weight calibration suggests a dimer or larger species.
Column calibration with protein standards is useful for orientation, but it does not prove the identity or exact mass of every sample peak. Orthogonal evidence, such as light scattering, analytical ultracentrifugation, or mass spectrometry, may be needed.
The method can change the equilibrium it measures
Aggregates may associate or dissociate as the sample is diluted, exposed to the mobile phase, and separated on the column. Reversible oligomers can shift during the run. Weak interactions with the stationary phase can delay a species; electrostatic exclusion can make it elute early.
Mobile-phase pH, ionic strength, additives, organic content, temperature, sample concentration, and injection volume all matter. An SEC percentage applies to the tested conditions, not automatically to every formulation or concentration.
Recovery is as important as the chromatogram
If aggregates adsorb to the vial, filter, tubing, frit, or column, the chromatogram can show an artificially clean monomer peak. Total recovered peak area relative to a suitable reference or injected amount helps reveal this problem.
Mass balance is especially important when comparing stressed and unstressed samples. A decline in aggregate area alongside a large decline in total recovery does not demonstrate aggregate removal; it may indicate loss within the method.
Reports should describe sample filtration and centrifugation. Removing visible particles before analysis may protect the instrument, but it changes which material is represented.
Detection response is not always uniform
UV detection estimates concentration through absorbance. If monomer and aggregate contain the same chromophores, their mass responses can be similar, but scattering and other effects may become significant for large species. Fragments with different chromophore content can respond differently.
Refractive-index detection is more broadly responsive but less sensitive and strongly affected by temperature and mobile-phase mismatch. Multi-angle light scattering coupled to SEC can estimate molar mass across a peak when concentration detection, detector alignment, and the refractive-index increment are suitable.
A reported area percent is therefore detector-specific.
“High molecular weight” is an operational category
SEC reports often divide areas into HMW, monomer, and LMW regions. Those windows should be defined using resolution, reference materials, or orthogonal characterization. A peak before monomer can also be a column-interaction artifact or an unrelated large species.
Likewise, a late peak can represent a fragment, excipient, solvent mismatch, or another small component. Retention region alone is not chemical identity.
Column resolution sets the blind spots
A column must have an appropriate fractionation range for the analyte. Very small peptides may sit near the total permeation range, where meaningful separation of monomer and small related species is poor. Very large aggregates can be excluded together near the void volume.
System suitability should challenge the separation actually needed. Useful measures can include monomer-aggregate resolution, peak tailing, plate count, retention-time repeatability, and standard recovery.
A report should make the experiment reproducible
Look for:
- column chemistry, dimensions, and pore range;
- mobile-phase composition and pH;
- flow rate and temperature;
- sample concentration and injection volume;
- pre-analysis filtration or centrifugation;
- detector type and wavelength;
- integration boundaries;
- system-suitability criteria;
- total recovery or mass-balance assessment;
- identification basis for HMW and LMW peaks.
For SEC-MALS, add detector calibration, interdetector delay, band-broadening correction, concentration detector, and dn/dc assumptions.
Stress studies need controls
SEC is frequently used after agitation, heating, freeze-thaw, light, or pH stress. A meaningful study uses unstressed controls, matched handling, adequate replication, and orthogonal particle methods when visible or subvisible particles are possible.
SEC primarily measures soluble species that enter and traverse the chromatographic system. It should not be treated as a complete particle assay.
Claims that go beyond the method
“98% monomer by SEC” does not establish:
- correct primary sequence;
- absence of covalent modifications;
- absence of subvisible particles;
- absence of reversible oligomers at another concentration;
- biological activity;
- stability throughout storage.
It states how detector area was distributed under one separation procedure.
Bottom line
SEC is powerful because it can resolve soluble species by hydrodynamic size without requiring denaturation. That same dependence on solution behavior, recovery, and column interactions limits interpretation. A trustworthy report pairs the area profile with recovery, suitability, and orthogonal identity evidence.
Sources
- United States Pharmacopeia. General Chapter <621> Chromatography.
- U.S. Food and Drug Administration. Analytical Procedures and Methods Validation for Drugs and Biologics.
- International Council for Harmonisation. Q2(R2): Validation of Analytical Procedures.
- International Council for Harmonisation. Q6B: Specifications, Biotechnological/Biological Products.
- Carpenter JF, et al. Overlooking subvisible particles in therapeutic protein products: gaps that may compromise product quality. Journal of Pharmaceutical Sciences. 2009.
Continue reading
Editorial responsibility and corrections
Published by Serum Research. Sources checked October 1, 2026. This is educational material; no independent scientific, clinical, statistical, analytical, or regulatory review is claimed. Read how we review evidence or send a correction.
For Research Use Only. Not for Human Consumption. This page does not provide instructions for medical use or establish the identity, quality, safety, or equivalence of a catalog material.